A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).
Clinical trial NCT04425538 · COMPLETED
Trial details
- NCT number
- NCT04425538
- Sponsor
- Tufts Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2021-01-22
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.